Abstract

BackgroundThe implementing Law 1015/2009 normalises the compassionate use of investigational drugs, access to off-label and unauthorised drugs in Spain.Rituximab is an anti-CD20 monoclonal antibody widely used in off-label conditions to...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call